Allergic Rhinitis News and Research

RSS
Experts offer myth-busting advice to fight against spring allergies

Experts offer myth-busting advice to fight against spring allergies

Meda's 2010 group sales decrease to SEK 11,571 million

Meda's 2010 group sales decrease to SEK 11,571 million

Teva reports positive results from QNAZE Phase III perennial allergic rhinitis trial

Teva reports positive results from QNAZE Phase III perennial allergic rhinitis trial

ASC launches ACT NOW to offer support, education about asthma and respiratory allergies

ASC launches ACT NOW to offer support, education about asthma and respiratory allergies

Merck reports GAAP net income of $861 million for 2010

Merck reports GAAP net income of $861 million for 2010

ISTA commences bepotastine besilate nasal spray Phase 2 study in seasonal allergic rhinitis

ISTA commences bepotastine besilate nasal spray Phase 2 study in seasonal allergic rhinitis

FDA approves Sun Pharma's generic Clarinex ANDA

FDA approves Sun Pharma's generic Clarinex ANDA

FDA grants Impax final approval for generic Allegra-D ANDA

FDA grants Impax final approval for generic Allegra-D ANDA

Teva presents QNAZE Phase III study results for SAR at ACAAI Meeting

Teva presents QNAZE Phase III study results for SAR at ACAAI Meeting

ACAAI scientific meeting to discuss pediatric allergies

ACAAI scientific meeting to discuss pediatric allergies

NUVO announces positive results from WF10 Phase 2 clinical trial for severe allergic rhinitis

NUVO announces positive results from WF10 Phase 2 clinical trial for severe allergic rhinitis

bitop includes first patient in Ectoin inhalation solution clinical trial for inflammation and airway obstruction

bitop includes first patient in Ectoin inhalation solution clinical trial for inflammation and airway obstruction

Merck reports $342 million net income for 2010 third quarter

Merck reports $342 million net income for 2010 third quarter

Cipla launches generic Pirfenidone for IPF

Cipla launches generic Pirfenidone for IPF

VentiRx announces VTX-1463 trial results for allergic rhinitis treatment

VentiRx announces VTX-1463 trial results for allergic rhinitis treatment

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

ISTA Pharmaceuticals announces Phase 1/2 clinical study results of bepotastine besilate nasal spray

Ragweed allergy season more miserable for people with dog, cat or dust mite allergies

Ragweed allergy season more miserable for people with dog, cat or dust mite allergies

ACAAI's survival tips for ragweed allergy

ACAAI's survival tips for ragweed allergy

Hayfever: time we moved exams to the winter?

Hayfever: time we moved exams to the winter?

Merck reports strong bottom-line performance in second quarter

Merck reports strong bottom-line performance in second quarter